<DOC>
	<DOCNO>NCT02086942</DOCNO>
	<brief_summary>This phase 2 study conduct 10 center enroll patient August 2013 August 2017.Firstly , All patient include provide write informed consent . Secondly , randomize equally receive modify VCD regimen arm 1 modified VCD regimen arm 2 . In total , 47 patient per arm ( 94 total ) require . The treatment consist four 4-week cycle induction therapy follow intensive therapy another five modify VCD regimens maintenance treatment CP regimen . Then , patient follow 24 month chemotherapy . The investigator record laboratory clinical investigation assess response different point study . We also monitor assess adverse event ( AEs ) , grade accord NCI-CTCAE Version 3.0.Response category base International Myeloma Working Group uniform response criteria.In addition , 20 patient ( 10 VCD regimen arm 1 group , 10 VCD regimen arm 2 group ) ten centre enrol pharmacodynamic substudy .</brief_summary>
	<brief_title>Tolerability Efficacy Modified VCD Regimens Previously Untreated Multiple Myeloma .</brief_title>
	<detailed_description />
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Bortezomib</mesh_term>
	<mesh_term>Teniposide</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>Patients previously untreated symptomatic MM 18 year age old , regardless gender secretory MM measurable disease Karnofsky Performance Status≥50 % （pathological fracture excluded） Patients without heart pulmonary dysfunction ≤class I peripheral neuropathy grade 2 high accord NCICTCAE Version 3.0 Relapse refractory MM MM without symptom Nonsecretory MM without measurable disease Karnofsky Performance Status＜50 % （pathological fracture excluded） Patients heart pulmonary dysfunction &gt; class I</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>